Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 404,100 | 498,600 | 295,700 | 420,400 | 471,000 |
| Marketable Securities | 1,111,000 | 985,500 | 535,900 | 516,500 | 286,600 |
| Receivables | 322,900 | 327,500 | 305,100 | 328,000 | 327,800 |
| Inventories | 303,600 | 317,100 | 308,000 | 308,900 | 313,900 |
| Income taxes - deferred | 29,500 | 42,800 | 35,400 | 33,400 | 41,300 |
| Other current assets | 89,600 | 60,300 | 77,200 | 71,800 | 83,200 |
| TOTAL | $2,309,200 | $2,278,100 | $1,603,300 | $1,725,800 | $1,570,400 |
| Non-Current Assets | |||||
| PPE Net | 429,300 | 422,500 | 418,700 | 421,600 | 409,000 |
| Investments And Advances | 92,000 | 99,000 | 95,200 | 21,900 | 20,700 |
| Intangibles | 404,800 | 413,800 | 417,000 | 418,900 | 446,900 |
| Other Non-Current Assets | 114,700 | 113,200 | 117,500 | 121,700 | 83,600 |
| TOTAL | $1,040,800 | $1,048,500 | $1,048,400 | $984,100 | $960,200 |
| Total Assets | $3,350,000 | $3,326,600 | $2,651,700 | $2,709,900 | $2,530,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 427,800 | 540,500 | 356,200 | 48,400 | 335,100 |
| Accrued Expenses | N/A | N/A | N/A | 297,200 | N/A |
| TOTAL | $427,800 | $540,500 | $356,200 | $345,600 | $335,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 596,400 | 598,000 | 725,400 | 593,100 | 532,100 |
| Other Non-Current Liabilities | 282,400 | 273,200 | 229,300 | 226,800 | 226,000 |
| TOTAL | $878,800 | $871,200 | $954,700 | $819,900 | $758,100 |
| Total Liabilities | $1,306,600 | $1,411,700 | $1,310,900 | $1,165,500 | $1,093,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 641,845 | 636,201 | 632,963 | 643,443 | 656,439 |
| Common Shares | 128,000 | 127,100 | 126,400 | 126,000 | 125,700 |
| Retained earnings | 2,732,700 | 2,638,100 | 2,091,100 | 2,030,800 | 1,969,800 |
| Other shareholders' equity | -70,300 | -40,700 | -32,400 | -27,600 | -43,100 |
| TOTAL | $2,043,400 | $1,914,900 | $1,340,800 | $1,544,400 | $1,437,400 |
| Total Liabilities And Equity | $3,350,000 | $3,326,600 | $2,651,700 | $2,709,900 | $2,530,600 |